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 Predictors of blood transfusion requirements in minimal invasive oesophagectomy have not been investigated so far.
 Highlighted are previously unreported predictors for blood transfusion requirement in minimally invasive oesophagectomy.
 Two of these factors may be addressed preoperatively and could guide treatment practice following further evaluation.
 Type of minimally invasive oesophagectomy was found to be an independent predictor for blood transfusion requirements.a r t i c l e i n f o
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Aim: To evaluate predictors of allogenic blood transfusion requirements in patients undergoing minimal
invasive oesophagectomy at a tertiary high volume centre for oesophago-gastric surgery. Methods:
Retrospective analysis of all patients undergoing minimal access oesophagectomy in our department
between January 2010 and December 2011. Patients were divided into two groups depending on whether
they required a blood transfusion at any time during their index admission. Factors that have been shown
to inﬂuence perioperative blood transfusion requirements in major surgery were included in the analysis.
Binary logistic regression analysis was performed to determine the impact of patient and perioperative
characteristics on transfusion requirements during the index admission. Results: A total of 80 patients
underwent minimal access oesophagectomy, of which 61 patients had a laparoscopic assisted oeso-
phagectomy and 19 patients had a minimal invasive oesophagectomy. Perioperative blood transfusion
was required in 28 patients at any time during hospital admission. On binary logistic regression analysis,
a lower preoperative haemoglobin concentration (p < 0.01), suffering a signiﬁcant complication
(p < 0.005) and laparoscopic assisted oesophagectomy (p < 0.05) were independent predictors of blood
transfusion requirements. Discussion: It has been reported that requirement for blood transfusion can
affect long-term outcomes in oesophageal cancer resection. Two factors which could be addressed
preoperatively; haemoglobin concentration and type of oesophageal resection, may be valuable in
predicting blood transfusions in patients undergoing minimally invasive oesophagectomy. Conclusion:
Our analysis revealed that preoperative haemoglobin concentration, occurrence of signiﬁcant compli-
cations and type of minimal access oesophagectomy predicted blood transfusion requirements in the
patient population examined.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.ctomy (performed via lapa-
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Oesophagectomy is a procedure associated with major
morbidity and a signiﬁcant risk of mortality [1]. There are also
longer term risks following surgery of recurrence disease and
indeed overall ﬁve year survival following surgery alone or com-
bined with neoadjuvant treatment is still only 25e46% [2,3]. It has
been shown that oesophagectomy has a signiﬁcant negative impact.
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returning to the preoperative baseline [4] after more than three
years. Several factors have been investigated that may inﬂuence
survival post oesophagectomy and these include TNM stage, pa-
tient age, postoperative complications (e.g. anastomotic leak, pul-
monary complications), resection margin status and perioperative
allogenic blood transfusion [5e8]. The need for transfusions in
patients undergoing oesophagectomy has been shown to have a
negative impact on long-term survival [9e11] and postoperative
morbidity [12]. This detrimental effect on survival has been
attributed to an immunosuppressive effect exerted by allogenic
blood transfusions. There may be other compounding factors such
as a positive correlation between the incidence of perioperative
complications and the number of blood transfusions [9e11]. Blood
transfusion requirements in open oesophagectomy have been
linked to age, postoperative complications, tumour stage and
anaemia [13].
Another factor inﬂuencing the need for blood transfusion may
be the approach by which oesophagectomy is carried out. Early
evidence shows that minimal access oesophagectomy may be
associated with decreased blood transfusion requirements [14,15].
The beneﬁt of minimal access approaches in terms of blood loss has
also been reported for other types of cancer resections. Factors that
may reduce intraoperative blood loss in minimal access surgery
include laparoscopic magniﬁcation of bleeding, decreased tissue
trauma and improved haemostatic techniques [16e18]. Minimal
access approaches to oesophagectomy are increasingly performed
in England [19,20] in an attempt to optimise recovery from surgery
and perhaps accelerate return of HRQL functions [21]. This trend is
mirrored at the Bristol Royal Inﬁrmary (BRI) which is a tertiary high
volume centre for oesophago-gastric surgery.
To the best of our knowledge, factors inﬂuencing transfusion
requirements in different types of minimal access oesophagectomy
have not been evaluated in the past. The aim of this study was to
determine predictors for perioperative transfusion requirements in
patients undergoing minimal access oesophagectomy at the BRI.
2. Patients and methods
Between January 2010 and December 2011 consecutive patients
undergoing a minimal access oesophagectomy at the BRI were
identiﬁed from a prospectively maintained database for inclusion
in the study. The time frame for inclusion in this study was chosen
because following a process of modiﬁcation and reﬁnement, the
operative technique for minimal access oesophagectomy was
standardised for all patients during this period. More recently pa-
tients undergoing oesophagectomy at our department have been
recruited for a prospective feasibility trial [25] and could therefore
not be included in this analysis. Patients diagnosed with cancer or
high grade dysplasia of the oesophagus were discussed at a
multidisciplinary meeting. If the tumour stage was T2 N0 M0 or
above patients were offered neoadjuvant chemotherapy in accor-
dance with the UK Medical Research Council OEO 2 protocol [22].
Staging investigations included high resolution CT, ﬂuorodeox-
yglucose positron emission tomography, endoscopic ultrasonog-
raphy and staging laparoscopy. Patients who were candidates for
oesophagectomy with curative intent were offered minimal access
surgery. In contrast, patients with a history of multiple previous
abdominal or thoracic surgery or a tumour involving the proximal
stomach were scheduled for open oesophagectomy. Patients un-
dergoing partial or total gastrectomy were not included in this
analysis.
Minimal access oesophagectomies at the BRI are performed, in
the main, as either a laparoscopically assisted oesophagectomy
(LAO) or as a totally minimally invasive oesophagectomy (MIO).LAO is a hybrid approach combining laparoscopic mobilisation of
the stomach and the gastro-oesophageal junction with a right
postero-lateral thoracotomy to enable an intra-thoracic anasto-
mosis to be fashioned. MIO is performed as a three-stage procedure
where the mobilisation of the oesophagus is performed via a
thoracoscopic approach with a cervical oesophago-gastric anasto-
mosis. Both procedures involve a radical two-ﬁeld lymphadenec-
tomy of the abdomen and the thorax.
Patients were divided into two groups depending on their
perioperative transfusion requirement; Tx e transfusion group;
NTx e no transfusion group. Indication for perioperative blood
transfusion was a haemoglobin concentration <8 g/dl or a patient
with symptomatic anaemia and a haemoglobin concentration
<10 g/dl.
Factors that have been shown to inﬂuence perioperative blood
transfusion requirements in major surgery were included in the
analysis. Variables included for analysis were type of surgery (LAO,
MIO), patient age, gender, estimated blood loss, preoperative hae-
moglobin concentration, occurrence of signiﬁcant postoperative
complications (ClavieneDindo classiﬁcation  3a), pathological
TNM stage (6th edition), resection margin status and the use of
neoadjuvant therapy. Details about these factors and transfusion
requirements were retrieved from the clinical notes, blood bank
records, multidisciplinary team notes, histopathology report,
anaesthetic chart, operation notes and drug charts. Patients with
missing datawere excluded. Continuous variables were checked for
normal distribution using the ShapiroeWilk test. Normally
distributed variables were compared using the two-tailed t-test.
For comparison of nonparametric variables we employed the
ManneWhitney test. Categorical variables were compared with the
chi-square or Fishers exact test as appropriate. When comparing
variables between patient groups, results are given as
mean ± standard error. Binary logistic regression analysis was
performed to determine the impact of patient and perioperative
characteristics on transfusion requirements during the index
admission. Blood transfusion at any time during index admission
was treated as a binary variable. Results of the regression analysis
are expressed as odds ratios with 95% conﬁdence intervals. A p-
value <0.05 was deemed statistically signiﬁcant. To estimate an
optimal preoperative haemoglobin concentration, Loess line ﬁtting,
receiver operating characteristic and visual binning were utilised.
3. Results
In the time period examined, 97 patients underwent oesopha-
gectomy at our department. Due to missing data 9 patients were
excluded from analysis with a further 8 patients excluded because
they had an open oesophagectomy. Minimal access oesophagec-
tomy was performed on a total of 80 patients of which 61 patients
underwent LAO compared with 19 patients who had a MIO. There
were 28 patients (Tx group) who received a blood transfusion on
index admission compared with 52 patients (NTx group) who did
not receive a blood transfusion. The mean preoperative Hb for the
Tx group was signiﬁcantly lower than in the NTx group 11.7 ± 0.3 g/
dl vs. 13.2 ± 0.3 g/dl respectively, (p < 0.0001). The estimated
operative blood loss was signiﬁcantly greater in the Tx group
compared with the NTx group 452 ± 101 ml vs. 286 ± 33 ml
respectively, (p < 0.02). Signiﬁcant complications occurred more
commonly in the Tx group compared with the NTx group, 12 vs. 8
complications respectively, (p < 0.02). Patients in the Tx group
stayed an average of 11 days longer in hospital during admission
(p < 0.0001) (Table 1).
Therewas no signiﬁcant difference in TNM stage between the Tx
and the NTx group (p < 0.3). The majority of oesophagectomies was
performed for adenocarcinoma of the oesophagus, 6 patients had
Table 2
Patient characteristics, histology and TNM stage LAO vs. MIO. Range for continuous
variables is given in brackets.
LAO n ¼ 61 MIO n ¼ 19 p-Value
Preoperative Hb
(g/dl)
12.3 ± 0.2 (7.9e16.6) 13.8 ± 0.4 (10.4e16.8) <0.001
Estimated blood
loss (ml)
400 ± 52 (100e3000) 165 ± 26 (20e500) <0.001
Gender m:f 3.07 3.75 1
Age 66.7 (45e79) 62.3 (35e74) <0.05
Complications 13 7 <0.25
Conversion to open 3 0 N.A.
Length of stay 17.3 ± 1.5 (9e64) 16.4 ± 2.2 (9e47) <1
Mortality 2 0 N.A.
Neoadjuvant therapy 45 7 <0.8
R1 resection 14 1 <0.2
Transfusion yes/no 26 2 <0.02
Units transfused 1.4 ± 0.4 (0e18) 0.8 ± 0.3 (0e4) <1
Histology









Key: AC e adenocarcinoma; SCC e squamous cell carcinoma; HGD e high grade
dysplasia.
a One patient with achalasia not included.
Table 1
Patient characteristics, histology and TNM stage transfusion vs. no-transfusion
group. Range for continuous variables is given in brackets.
Transfusion n ¼ 28 No transfusion n ¼ 52 p-Value
Preoperative Hb
(g/dl)
11.7 ± 0.3 (7.9e16.8) 13.2 ± 0.3 (9.9e16.6) <0.0001
Estimated blood
loss (ml)
452 ± 101 (20e3000) 286.1 ± 33 (20e1500) <0.015
Gender m:f 2.5 3.73 <0.6
Age 66.2 (35.8e79.3) 65.3 (45.4e77.5) <0.7






23.9 ± 2.7 (9e64) 13.4 ± 0.9 (9e47) <0.0001




MIO 2 17 <0.014
R1 resection 6 9 <0.42
Histology









Key: AC e adenocarcinoma; SCC e squamous cell carcinoma; HGD e high-grade
dysplasia.
a One patient with achalasia not included.
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for achalasia (Table 1.).
A decreased preoperative Hb (OR -0.58, CI 0.37e0.84, p < 0.01),
suffering a signiﬁcant complication (OR 2.3, CI 2.2e42.7, p < 0.005)
or undergoing a LAO (OR 1.9, CI 1.01e42.28, p < 0.05) were inde-
pendent predictors for receiving a blood transfusion at any point
during hospital admission. Patient age, gender, TNM stage, resec-
tion margin status, estimated blood loss and receiving neoadjuvant
therapy did not predict blood transfusion requirements on index
admission (p > 0.05).
As the type of minimal access oesophagectomy was an inde-
pendent predictor for blood transfusion requirements, we choose
to compare the characteristics of patients undergoing LAO vs. MIO.
Preoperative Hb concentrationwas signiﬁcantly higher 13.8 ± 0.4 g/
dl vs. 12.3 ± 0.2 g/dl (p < 0.001) whereas estimated blood loss was
lower 165 ± 26 ml vs. 400 ± 52 ml (p < 0.001) in the MIO group.
Patients undergoing MIO were younger 62.3 vs. 66.7 years
(p < 0.05) and had less advanced tumours (p < 0.03), despite this
the number of complications did not differ signiﬁcantly 7 vs. 13
(p < 0.3) MIO and LAO group respectively (Table 2).
Loess line ﬁtting is a non-parametric, exploratory method of
ﬁtting smooth curves to scatter plots where variables are likely to
be dependent in a non-linear fashion. The shallow course of the
slope at Hb concentrations of 12.5 g/dl or greater indicates that
within this range there is very little inﬂuence of the Hb concen-
tration on postoperative blood transfusion requirement (Fig. 1).
Patients were binned into categories depending on their pre-
operative Hb. Visual binning revealed a trend towards less trans-
fusion requirements in patients with higher preoperative Hb
concentrations. A plateau in transfusion requirements was reached
at Hb  12.5 g/dl (Fig. 2). A receiver operating characteristic curve
analysis revealed that preoperative Hb concentration was a fair
predictor of transfusion requirements (Area under Curve 0.75 ± 0.6,
CI 0.64e0.86) (Fig. 3). Based on the above ﬁndings we estimated the
optimal preoperative Hb concentration to be 12.5e13 g/dl.4. Discussion
In the patient cohort examined, preoperative haemoglobin
concentration, signiﬁcant postoperative complications and the type
of minimal access oesophagectomywere independent predictors of
transfusion requirement at any point during the index admission.
Contrary to another report [13] patient age did not inﬂuence blood
transfusion requirement at any stage of recovery. The cut off point
where a further increase in preoperative Hb concentration did not
reduce the postoperative requirements for blood transfusion is
estimated to be 12.5e13 g/dl.
This analysis is a retrospective analysis from a single centre and
therefore has all the limitations inherent to this type of study.
However, most publications regarding minimal access oesopha-
gectomy have been single centre experiences [23,24,26] or analyses
of national registries [19,20] with very little prospective data to
compare outcome with the type of minimal access oesophagec-
tomy. To the authors' knowledge the predictors of postoperative
blood transfusion requirements have not been studied in a
contemporary cohort of patients undergoing minimal access
oesophagectomy.
The TNM stage has been shown to be predictive for the need of
blood transfusion in a study of patients undergoing open oeso-
phagectomy [13]. Because of the technical challenges involved in
minimal access oesophagectomy it is likely that patients with very
advanced or bulky tumours were deemed unsuitable for this
approach and are therefore not included in our analysis. It is
possible that this preoperative selection process has biased the
impact of TNM stage on blood transfusion requirement. The patient
population described here almost exclusively consists of adeno-
carcinoma of the oesophagus and the gastro-oesophageal junction,
which is representative of most western oesophago-gastric units
but may not allow direct comparison with populations where
squamous cell carcinoma is more predominant.
Most reports regarding MIO have been focused on safety and
feasibility of the procedure and there is very little data to compare
outcomes following either LAO or MIO. One group reported
Fig. 1. Loess line ﬁtted on scatter plot of total blood units transfused and preoperative Hb concentration.
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but other postoperative outcomes were found to be similar to LAO
and totally oesophagectomy [24]. The data presented here shows
that patients undergoing MIO are less likely to require bloodFig. 2. Visual binning of preoperative Hb compared to ptransfusion during hospital admission. Hypothetically this could be
due to a combination of factors. Firstly, it is noted that no patient in
the MIO group compared with three patients in the LAO group
required conversion open oesophagectomy. Conversion to openercentage of patients requiring blood transfusion.
Fig. 3. ROC curve analysis of preoperative Hb as a predictor for blood transfusion requirement.
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in other laparoscopic procedures [27]. Secondly, intraoperative
visualisation of bleeding is enhanced in laparoscopic and thoraco-
scopic surgery and this approach has been shown to be associated
with decreased intraoperative blood loss in the resection of oeso-
phageal and other gastrointestinal cancers [18].
Knowledge of the optimal preoperative Hb may be used to
optimise patients preoperatively and avoid the potentially negative
impact of allogenic blood transfusions [9e11] in patients under-
going oesophagectomy.
Postoperative complications are more likely to occur in techni-
cally difﬁcult cases and this may explain the association of this
factor with increased blood transfusion requirements. MIO is a
technically challenging procedure which has not been widely
adopted at this time. It is for this reason, that we feel it would be
unjustiﬁed to advocate MIO over LAO in an attempt to reduce
intraoperative blood loss, however further evaluation of this
ﬁnding in future studies would be warranted.
Of the three factors we found to be signiﬁcant predictors, the
preoperative Hb can readily be addressed preoperatively. The
substitution of allogenic with autologous blood transfusion has
been shown to favourably affect survival in patients who under-
went oesophagectomy in one study [16]. However, adopting this
approach into routine practice will not be feasible in a large pro-
portion of cases. Other authors have used preoperative intravenous
iron sucrose infusion to correct iron deﬁciency anaemia in patients
undergoing elective orthopaedic surgery [28]. Signiﬁcant reduction
in perioperative morbidity and mortality after cardiac valve
replacement has been shown in patients receiving a combination
therapy of intravenous iron sucrose infusion and erythropoietin
[29].
In summary, our analysis has shown that preoperative haemo-
globin concentration, occurrence of signiﬁcant complications and
type of minimal access oesophagectomy predicted blood trans-
fusion requirements in the patient population examined.Ethical approval
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